Compare NEO & PGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NEO | PGY |
|---|---|---|
| Founded | 2001 | 2016 |
| Country | United States | United States |
| Employees | N/A | 511 |
| Industry | Precision Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2008 | N/A |
| Metric | NEO | PGY |
|---|---|---|
| Price | $9.16 | $12.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | $13.38 | ★ $34.50 |
| AVG Volume (30 Days) | 2.0M | ★ 3.5M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.63 | $14.27 |
| Revenue Next Year | $9.73 | $14.39 |
| P/E Ratio | ★ N/A | $13.54 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.72 | $10.40 |
| 52 Week High | $13.74 | $44.99 |
| Indicator | NEO | PGY |
|---|---|---|
| Relative Strength Index (RSI) | 58.70 | 44.24 |
| Support Level | $7.42 | $12.77 |
| Resistance Level | $10.82 | $15.57 |
| Average True Range (ATR) | 0.40 | 0.88 |
| MACD | 0.03 | -0.20 |
| Stochastic Oscillator | 78.90 | 13.73 |
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
Pagaya Technologies Ltd is a product-focused technology company. It uses machine learning, a vast data network, and an AI-driven approach to offer comprehensive consumer credit and residential real estate products for its partners, their customers, and investors. Its suite of products includes Decline Monetization, Dual Look, First Look, Affiliate Optimizer Engine, Direct Marketing Engine, and FastPass, providing lenders with an AI-powered credit and acquisition ecosystem that helps them approve more borrowers, capture more demand, and grow without adding risk. Geographically, the company generates maximum revenue from its business in the United States.